This federal Project Grant award of $725,088, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), supports research to optimize the effectiveness and implementation of COPD self-management treatment.
The key products or services to be delivered through this award include: 1) conducting a factorial optimization trial among 448 individuals with COPD to assess the effectiveness of self-management education, physical activity, and inhaler training components, with the primary outcome of 12-month respiratory-related hospitalizations and secondary outcome of health-related quality of life; and 2) performing a mixed-method process evaluation to identify barriers and facilitators impacting program referrals and implementation strategies to increase referrals to a remotely-delivered COPD self-management program. The award aims to advance understanding of COPD self-management treatment components and optimize an effective, efficient, affordable, and scalable COPD self-management program.